Modus Therapeutics Holding AB (publ) (STO:MODTX)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.2930
-0.0090 (-2.98%)
At close: Mar 4, 2026

STO:MODTX Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
7.326.737.836.997.09
Research & Development
10.859.078.4810.913.54
Other Operating Expenses
-0.020.040.090.120.05
Operating Expenses
18.1415.8416.418.0120.69
Operating Income
-18.14-15.84-16.4-18.01-20.69
Interest Expense
---1.5-0.31-0
Interest & Investment Income
-0.290--
Other Non Operating Income (Expenses)
-0.4--0--
Pretax Income
-18.54-15.55-17.9-18.32-20.69
Net Income
-18.54-15.55-17.9-18.32-20.69
Net Income to Common
-18.54-15.55-17.9-18.32-20.69
Shares Outstanding (Basic)
6236181612
Shares Outstanding (Diluted)
6236181612
Shares Change (YoY)
71.99%102.53%10.22%30.09%109.34%
EPS (Basic)
-0.30-0.43-1.01-1.14-1.67
EPS (Diluted)
-0.30-0.43-1.01-1.14-1.67
EBIT
-18.14-15.84-16.4-18.01-20.69
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.